This session presents the latest information and research on the use of current FDA-approved medications for osteoporosis prevention and/or treatment. The focus of this session will be on anabolic agents and biologic therapy. It will explore what a biologic is and how it differs from a medication, mechanism of action of anabolic agents and biologics, clinical issues with PTH and denosumab, when to consider these therapies, and patient management and followup - when & how to monitor.